We identified ligands and signaling pathways that have implicated in IBD, such as interleukin-1β (IL-1β), supporting the validity of the approach, along with unexpected ligands, such as granzyme B, which may play previously unappreciated roles in IBD. The gene discussed is IL1B; the disease is inflammatory bowel disease.